Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP211700.RAJcHFhfR5byRgRt1zAWH7LYDp2e4QyQpdk65aRCfUDtU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP211700.RAJcHFhfR5byRgRt1zAWH7LYDp2e4QyQpdk65aRCfUDtU130_assertion type Assertion NP211700.RAJcHFhfR5byRgRt1zAWH7LYDp2e4QyQpdk65aRCfUDtU130_head.
- NP211700.RAJcHFhfR5byRgRt1zAWH7LYDp2e4QyQpdk65aRCfUDtU130_assertion description "[in breast cancer patients, Akt activation is associated with tumour proliferation and poor prognosis, particularly in the subset of patients with ErbB2-overexpressing tumours ]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP211700.RAJcHFhfR5byRgRt1zAWH7LYDp2e4QyQpdk65aRCfUDtU130_provenance.
- NP211700.RAJcHFhfR5byRgRt1zAWH7LYDp2e4QyQpdk65aRCfUDtU130_assertion evidence source_evidence_literature NP211700.RAJcHFhfR5byRgRt1zAWH7LYDp2e4QyQpdk65aRCfUDtU130_provenance.
- NP211700.RAJcHFhfR5byRgRt1zAWH7LYDp2e4QyQpdk65aRCfUDtU130_assertion SIO_000772 15987444 NP211700.RAJcHFhfR5byRgRt1zAWH7LYDp2e4QyQpdk65aRCfUDtU130_provenance.
- NP211700.RAJcHFhfR5byRgRt1zAWH7LYDp2e4QyQpdk65aRCfUDtU130_assertion wasDerivedFrom lhgdn-20090331 NP211700.RAJcHFhfR5byRgRt1zAWH7LYDp2e4QyQpdk65aRCfUDtU130_provenance.
- NP211700.RAJcHFhfR5byRgRt1zAWH7LYDp2e4QyQpdk65aRCfUDtU130_assertion wasGeneratedBy ECO_0000203 NP211700.RAJcHFhfR5byRgRt1zAWH7LYDp2e4QyQpdk65aRCfUDtU130_provenance.